» Articles » PMID: 2557758

Human Papillomaviruses and Carcinomas

Overview
Journal Adv Virus Res
Specialty Microbiology
Date 1989 Jan 1
PMID 2557758
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The recognition of multiple types of human papillomaviruses has resulted in remarkable progress in the detection of persisting viral nucleic acid sequences in carcinomas. The consistent transcription in tumors of two early open reading frames, E6 and E7, with few exceptions (Lehn et al., 1985), indicates a role for the products of these genes in the induction and/or maintenance of the transformed state. A number of studies have shown that in vitro transformation can be achieved by transfection of E6/E7 DNA, and proteins encoded by these DNA sequences can be demonstrated in primary human keratinocytes immortalized by this DNA (Kaur et al., 1989). Mutagenesis experiments are needed to determine the absolute requirement for and function of these genes in transformation. A preferential association of some types with benign lesions while others may be frequently found in malignant tumors has been observed. HPV types 5 and 8 in epidermodysplasia verruciformis patients and types 16, 18, 31, 33, etc. in genital lesions are most frequently associated with progression to malignancy, whereas other types, such as HPV-6,-10, -11, and -20, are regularly identified in benign warts. Such distinctions are not absolute but provide the initial steps toward establishing a causal role for some human papillomaviruses in carcinomas. The need for well-designed epidemiological studies in concert with optimum molecular and serologic evaluations is evident (Armstrong et al., 1988). The data from human and animal studies indicate that papillomaviruses contribute significantly to the development of many, if not all, carcinomas, but we do not yet have a clear understanding of the importance of other interacting viral, chemical, or cellular factors. The application of gene cloning and non-stringent hybridization (Law et al., 1979) has provided us with an apparently ever-increasing catalog of human papillomaviruses. More effort is now required to establish their prevalence, the natural history of infection, and the mechanism of neoplastic transformation.

Citing Articles

Disparities in prostate cancer incidence and mortality rates: Solvable or not?.

Badal S, Aiken W, Morrison B, Valentine H, Bryan S, Gachii A Prostate. 2019; 80(1):3-16.

PMID: 31702061 PMC: 8378246. DOI: 10.1002/pros.23923.


Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient.

Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J Int J Oncol. 2010; 37(6):1477-82.

PMID: 21042716 PMC: 3132581. DOI: 10.3892/ijo_00000800.


Human papillomavirus associated with oesophageal cancer.

Matsha T, Erasmus R, Kafuko A, Mugwanya D, StEpieN A, Parker M J Clin Pathol. 2002; 55(8):587-90.

PMID: 12147651 PMC: 1769715. DOI: 10.1136/jcp.55.8.587.


A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer.

OConnor M, Stunkel W, Zimmermann H, Koh C, Bernard H J Virol. 1998; 72(12):10083-92.

PMID: 9811748 PMC: 110540. DOI: 10.1128/JVI.72.12.10083-10092.1998.


Immunological ignorance of an E7-encoded cytolytic T-lymphocyte epitope in transgenic mice expressing the E7 and E6 oncogenes of human papillomavirus type 16.

Melero I, Singhal M, McGowan P, Haugen H, Blake J, Hellstrom K J Virol. 1997; 71(5):3998-4004.

PMID: 9094677 PMC: 191552. DOI: 10.1128/JVI.71.5.3998-4004.1997.